Screener
Jazz Pharmaceuticals JAZZ Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
FAQ
- What is Jazz Pharmaceuticals's current ratio?
- Jazz Pharmaceuticals (JAZZ) reported current ratio of 2× in Q1 2026.
- How has Jazz Pharmaceuticals's current ratio changed year-over-year?
- Jazz Pharmaceuticals's current ratio decreased by 39.6% year-over-year, from 3.4× to 2×.
- What is the long-term trend for Jazz Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's current ratio has grown at a -15.6% compound annual growth rate (CAGR), from 4.3× to 1.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Jazz Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude